Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With Atrial Fibrillation

BACKGROUND: EAST‐AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) demonstrated clinical benefit of early rhythm‐control therapy (ERC) in patients with new‐onset atrial fibrillation (AF) and concomitant cardiovascular conditions compared with current guideline‐based practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickow, Jannis, Kirchhof, Paulus, Van Houten, Holly K., Sangaralingham, Lindsey R., Dinshaw, Leon H. W., Friedman, Paul A., Packer, Douglas L., Noseworthy, Peter A., Yao, Xiaoxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238730/
https://www.ncbi.nlm.nih.gov/pubmed/35621202
http://dx.doi.org/10.1161/JAHA.121.024214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238730/
https://www.ncbi.nlm.nih.gov/pubmed/35621202
http://dx.doi.org/10.1161/JAHA.121.024214

Ejemplares similares